Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Arcutis Biotherapeutics Inc (NASDAQ: ARQT)

 
ARQT Technical Analysis
5
As on 9th Jun 2023 ARQT STOCK Price closed @ 9.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 19.76 & Strong Sell for SHORT-TERM with Stoploss of 17.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ARQTSTOCK Price

Open 10.01 Change Price %
High 10.15 1 Day -0.07 -0.70
Low 9.72 1 Week 2.13 27.27
Close 9.94 1 Month -3.96 -28.49
Volume 990200 1 Year -7.13 -41.77
52 Week High 26.95 | 52 Week Low 7.51
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ARQT
Daily Charts		 ARQT
Intraday Charts		 Whats New @
Bazaartrend		 ARQT
Free Analysis
 
ARQT Important Levels Intraday
RESISTANCE10.77
RESISTANCE10.50
RESISTANCE10.34
RESISTANCE10.17
SUPPORT9.71
SUPPORT9.54
SUPPORT9.38
SUPPORT9.11
 
ARQT Forecast May 2024
Share
4th UP Forecast27.82
3rd UP Forecast22.09
2nd UP Forecast18.54
1st UP Forecast15
1st DOWN Forecast4.88
2nd DOWN Forecast1.34
3rd DOWN Forecast-2.21
4th DOWN Forecast-7.94
 
ARQT Weekly Forecast
4th UP Forecast19.13
3rd UP Forecast16.18
2nd UP Forecast14.36
1st UP Forecast12.54
1st DOWN Forecast7.34
2nd DOWN Forecast5.52
3rd DOWN Forecast3.70
4th DOWN Forecast0.75
 
ARQT Forecast2024
4th UP Forecast48.77
3rd UP Forecast36.32
2nd UP Forecast28.62
1st UP Forecast20.92
1st DOWN Forecast-1.04
2nd DOWN Forecast-8.74
3rd DOWN Forecast-16.44
4th DOWN Forecast-28.89
 
 
ARQT Other Details
Segment EQ
Market Capital 1087232512.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ARQT Address
ARQT
 
ARQT Latest News
 
Your Comments and Response on Arcutis Biotherapeutics Inc
 
ARQT Business Profile
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. Address: 3027 Townsgate Road, Westlake Village, CA, United States, 91361
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service